Photo from Arthur Pereira on Unsplash
In the cosmetic industry, creativity and innovation are optional, but regulatory compliance is mandatory. With the FDA ramping up enforcement and new laws, such as the Modernization of Cosmetics Regulation Act (MoCRA), beauty brands must stay informed to remain compliant and competitive.
If you’re building a brand or launching a product, understanding the FDA’s role and requirements is critical. Here’s what you need to know to stay ahead of the curve.
The U.S. Food & Drug Administration (FDA) regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FD&C Act). However, it’s important to understand the distinction between cosmetics and drugs:
If your product makes therapeutic claims—like “heals eczema” or “stimulates collagen production”—it may be considered a drug, even if it's sold in the beauty aisle. That distinction is key and will affect everything from how your product is tested to how it’s labeled.
Proper cosmetic labeling isn’t just about the branding; it’s a legal requirement. The FDA has strict guidelines for what must appear on your product’s label, including:
Failing to meet these requirements could result in products being classified as misbranded and pulled from the market.
Marketing language is one of the biggest pitfalls for new brands. While “hydrates skin” or “adds shine” are acceptable cosmetic claims, phrases like “treats rosacea,” “boosts collagen production,” or “reduces inflammation” can land your product in drug territory, which is under heavy FDA supervision.
Avoid drug-like claims unless you are prepared to go through the drug approval process. Stick to benefits that are legally allowed for cosmetics unless you’ve worked with a regulatory expert.
To protect your brand:
Work with a manufacturer or consultant who understands compliance language
Although the FDA does not currently mandate GMPs for cosmetics, it expects manufacturers to follow them, and this will change under MoCRA. GMPs ensure your products are:
Cosmetic brands must be prepared for post-market obligations, especially under MoCRA. As of 2023, serious adverse events (like infections, hospitalizations, or allergic reactions) must be reported to the FDA within 15 business days.
Brands must:
The Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022, marks a major shift in how the FDA oversees cosmetics. For the first time, cosmetics companies are required to comply with several mandates that were previously voluntary or loosely enforced.
MoCRA represents a massive regulatory evolution, and brands that prepare now will be well-positioned to grow sustainably in a more transparent industry.
If you’re planning to sell internationally, FDA compliance is just the start. Each region has its own regulatory body:
Working with a manufacturing partner who understands these requirements can save you time, money, and legal hassle.
Navigating regulatory hurdles can be overwhelming, but you don’t have to do it alone. As a full-service contract manufacturer, we help brands:
Our job is to keep your brand safe, compliant, and market-ready—so you can focus on growth, not red tape.
FDA compliance isn’t just about avoiding penalties, but it’s about building trust with your customers, your retailers, and your investors. With MoCRA bringing sweeping changes to the U.S. cosmetics landscape, brands that take a proactive, well-informed approach to regulation will lead the future of beauty.
Whether you’re just getting started or ready to scale, partnering with an experienced contract manufacturer can ensure you’re prepared for every phase of regulatory responsibility.